PORTLAND, Ore., June 25, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Comfortear® Lacrisolve™ Absorbable Punctum Plug.

“Receiving FDA 510(k) clearance for this device is an important milestone for Paragon. Dry eye affects over 4.8 million people in the U.S. and, keeping with Paragon’s ultimate goal to protect and preserve eyesight, the Comfortear Lacrisolve Absorbable Punctum Plug is a great addition to our portfolio of FDA regulated ophthalmic products,” says Lauren M-C Bluett, Director of Quality Assurance.

About Comfortear® Lacrisolve™ Absorbable Punctum Plug:

Comprised of the synthetic absorbable polymer, polydioxanone, the Comfortear® Lacrisolve™ Absorbable Punctum Plugs are medium-term implants designed to be inserted into the canaliculus in order to block tear drainage through the lacrimal drainage system. The Comfortear® Lacrisolve™ Absorbable Punctum Plugs are available in two diameters: 0.4mm and 0.5mm. The implants are supplied sterile with two implants per package.

Absorption time for the Comfortear® Lacrisolve™ Absorbable Punctum Plugs is approximately 6 months (=<6). For full prescribing information, visit http://www.paragonbioteck.com/.

Product Availability:

The Comfortear® Lacrisolve™ Absorbable Punctum Plugs will ship July 2014. To preorder or learn more about Paragon’s products, call 888-424-1192. Product orders or inquiries can also be sent to orders@paragonbioteck.com.

For up to date information on Paragon BioTeck, Inc., subscribe to its newsletter to receive important information regarding the product launch, special offers and more.

About Paragon BioTeck, Inc.:

Paragon BioTeck is a privately held ophthalmic-focused biopharmaceutical and medical device company pursuing the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight.

For more information on the company and its work, please visit http://www.paragonbioteck.com/ or call 888-424-1192; or email info@paragonbioteck.com.

*PHOTO: Send2Press.com/mediaboom/14-0625-comfortear_300dpi.jpg .
*Photo Caption: Comfortear® Lacrisolve™ Absorbable Punctum Plugs.

Twitter: @paragonbioteck

News issued by: Paragon BioTeck, Inc.

Paragon BioTeck, Inc.

Original Image: https://www.send2press.com/mediaboom/14-0625-comfortear_500x375.jpg

# # #

Original Story ID: 2014-06-0625-001 (9483) :: Paragon-BioTeck-Inc-Receives-FDA-Clearance-for-Comfortear-Lacrisolve-Absorbable-Punctum-Plug_2014-06-0625-001

Original Keywords: ophthalmic pharmaceuticals, Comfortear Lacrisolve Absorbable Punctum Plug Paragon BioTeck, Inc. Portland Oregon PORTLAND, Ore.

Alternate Headline: Paragon BioTeck Receives 510(k) clearance from the Food and Drug Administration for its Comfortear Lacrisolve Absorbable Punctum Plug

NEWS ARCHIVE NOTE: this archival news content, issued by the news source via Send2Press Newswire, was originally located in the Send2Press® 2004-2015 2.0 news platform and has been permanently converted/moved (and redirected) into our 3.0 platform. Also note the story “reads” counter (bottom of page) does not include any data prior to Oct. 30, 2016. This press release was originally published/issued: Wed, 25 Jun 2014 15:04:47 +0000

Original Shortcode for Story: http://i.send2press.com/ABMOK

News Source: Paragon BioTeck, Inc.